146 related articles for article (PubMed ID: 9191875)
21. Treatment of high-grade glioma patients with the humanized anti-epidermal growth factor receptor (EGFR) antibody h-R3: report from a phase I/II trial.
Ramos TC; Figueredo J; Catala M; González S; Selva JC; Cruz TM; Toledo C; Silva S; Pestano Y; Ramos M; Leonard I; Torres O; Marinello P; Pérez R; Lage A
Cancer Biol Ther; 2006 Apr; 5(4):375-9. PubMed ID: 16575203
[TBL] [Abstract][Full Text] [Related]
22. Effects of anti-epidermal growth factor (EGF) receptor antibodies and an anti-EGF receptor recombinant-ricin A chain immunoconjugate on growth of human cells.
Taetle R; Honeysett JM; Houston LL
J Natl Cancer Inst; 1988 Sep; 80(13):1053-9. PubMed ID: 3261802
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M
Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of epidermal growth factor receptor expression on glioma cells by recombinant tumor necrosis factor alpha.
Adachi K; Belser P; Bender H; Li D; Rodeck U; Benveniste EN; Woo D; Schmiegel WH; Herlyn D
Cancer Immunol Immunother; 1992; 34(6):370-6. PubMed ID: 1563013
[TBL] [Abstract][Full Text] [Related]
25. Novel monoclonal antibody specific for the de2-7 epidermal growth factor receptor (EGFR) that also recognizes the EGFR expressed in cells containing amplification of the EGFR gene.
Johns TG; Stockert E; Ritter G; Jungbluth AA; Huang HJ; Cavenee WK; Smyth FE; Hall CM; Watson N; Nice EC; Gullick WJ; Old LJ; Burgess AW; Scott AM
Int J Cancer; 2002 Mar; 98(3):398-408. PubMed ID: 11920591
[TBL] [Abstract][Full Text] [Related]
26. Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225.
Ciardiello F; Bianco R; Damiano V; De Lorenzo S; Pepe S; De Placido S; Fan Z; Mendelsohn J; Bianco AR; Tortora G
Clin Cancer Res; 1999 Apr; 5(4):909-16. PubMed ID: 10213228
[TBL] [Abstract][Full Text] [Related]
27. Anti-idiotypic response to antigrowth factor receptor monoclonal antibodies.
Tosi E; Valota O; Canevari S; Adobati E; Casalini P; Perez P; Colnaghi MI
Eur J Cancer; 1996 Mar; 32A(3):498-505. PubMed ID: 8814698
[TBL] [Abstract][Full Text] [Related]
28. Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A.
Ciardiello F; Damiano V; Bianco R; Bianco C; Fontanini G; De Laurentiis M; De Placido S; Mendelsohn J; Bianco AR; Tortora G
J Natl Cancer Inst; 1996 Dec; 88(23):1770-6. PubMed ID: 8944008
[TBL] [Abstract][Full Text] [Related]
29. [Immunohistochemical studies of advanced laryngeal and hypopharyngeal carcinomas 3 days after administration of monoclonal antibody against epidermal growth factor receptor].
Haas I; Koldovsky P; Bier H
Laryngorhinootologie; 1994 Dec; 73(12):626-30. PubMed ID: 7840824
[TBL] [Abstract][Full Text] [Related]
30. In vivo evaluation of epidermal growth factor (EGF) receptor density on human tumor xenografts using radiolabeled EGF and anti-(EGF receptor) mAb 425.
Senekowitsch-Schmidtke R; Steiner K; Haunschild J; Möllenstädt S; Truckenbrodt R
Cancer Immunol Immunother; 1996 Feb; 42(2):108-14. PubMed ID: 8620519
[TBL] [Abstract][Full Text] [Related]
31. AMG 595, an Anti-EGFRvIII Antibody-Drug Conjugate, Induces Potent Antitumor Activity against EGFRvIII-Expressing Glioblastoma.
Hamblett KJ; Kozlosky CJ; Siu S; Chang WS; Liu H; Foltz IN; Trueblood ES; Meininger D; Arora T; Twomey B; Vonderfecht SL; Chen Q; Hill JS; Fanslow WC
Mol Cancer Ther; 2015 Jul; 14(7):1614-24. PubMed ID: 25931519
[TBL] [Abstract][Full Text] [Related]
32. Effect of a bifunctional monoclonal antibody directed against a tumor marker and doxorubicin on the growth of epidermoid vulvar carcinoma grafted in athymic mice.
Morelli D; Ménard S; Pozzi B; Balsari A; Colnaghi MI
Cell Biophys; 1994; 24-25():119-26. PubMed ID: 7736515
[TBL] [Abstract][Full Text] [Related]
33. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
Fan Z; Masui H; Altas I; Mendelsohn J
Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
[TBL] [Abstract][Full Text] [Related]
34. Comparison of intratumoral bolus injection and convection-enhanced delivery of radiolabeled antitenascin monoclonal antibodies.
Sampson JH; Akabani G; Friedman AH; Bigner D; Kunwar S; Berger MS; Bankiewicz KS
Neurosurg Focus; 2006 Apr; 20(4):E14. PubMed ID: 16709019
[TBL] [Abstract][Full Text] [Related]
35. Characterization of two monoclonal antibodies against the COOH-terminal part of the human epidermal growth factor receptor and potential clinical use.
Troalen F; Maudelondé T; Montcourrier P; Bohuon C; Delarue JC
J Immunol Methods; 1991 Oct; 143(2):175-86. PubMed ID: 1719099
[TBL] [Abstract][Full Text] [Related]
36. In vivo therapeutic synergism of anti-epidermal growth factor receptor and anti-HER2 monoclonal antibodies against pancreatic carcinomas.
Larbouret C; Robert B; Navarro-Teulon I; Thèzenas S; Ladjemi MZ; Morisseau S; Campigna E; Bibeau F; Mach JP; Pèlegrin A; Azria D
Clin Cancer Res; 2007 Jun; 13(11):3356-62. PubMed ID: 17545543
[TBL] [Abstract][Full Text] [Related]
37. Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer.
Modjtahedi H; Hickish T; Nicolson M; Moore J; Styles J; Eccles S; Jackson E; Salter J; Sloane J; Spencer L; Priest K; Smith I; Dean C; Gore M
Br J Cancer; 1996 Jan; 73(2):228-35. PubMed ID: 8546911
[TBL] [Abstract][Full Text] [Related]
38. The epidermal growth factor receptor as a target for cancer therapy.
Mendelsohn J
Endocr Relat Cancer; 2001 Mar; 8(1):3-9. PubMed ID: 11350723
[TBL] [Abstract][Full Text] [Related]
39. Depatuxizumab Mafodotin (ABT-414)-induced Glioblastoma Cell Death Requires EGFR Overexpression, but not EGFR
von Achenbach C; Silginer M; Blot V; Weiss WA; Weller M
Mol Cancer Ther; 2020 Jun; 19(6):1328-1339. PubMed ID: 32371586
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice.
Aboud-Pirak E; Hurwitz E; Pirak ME; Bellot F; Schlessinger J; Sela M
J Natl Cancer Inst; 1988 Dec; 80(20):1605-11. PubMed ID: 3193478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
